Objective: A strong independent association between the prothrombin G20210A
gene mutation and pre-eclampsia has been reported in an Italian population
. This result was not confirmed in a subsequent study in a Dutch population
. The objective of this study was to further test the hypothesis that the p
rothrombin G20210A mutation is associated with pre-eclampsia/eclampsia. Met
hods: Seventeen eclamptics and 67 pre-eclamptics were recruited from 34 mul
ticase Australian/New Zealand families. An additional 105 unrelated pre-ecl
amptic/ eclamptic women and 119 parous women were recruited as controls. Re
sults: The overall incidence for the prothrombin G20210A gene mutation in t
he pre-eclamptic group was 3.6% (95% Cl 1.2-8.2%) which was not significant
ly different from the control group 2.5% (95% Cl 0.57.2%) (p = 0.73, OR 1.4
4, 95% Cl 0.34-6.17). Conclusion: This study provides little evidence of a
significant relationship between the prothrombin G20210A gene mutation and
pre-eclampsia. Based on our results, we do not recommend testing for the pr
othrombin G20210A mutation in the routine investigation of women with pre-e
clampsia. Copyright (C) 2000 S. Karger AG, Basel.